文献速递冠心病血脂与心血管预防

糖尿病疑似冠心病患者:负荷试验与CT血管造影的比较

Stress Testing Versus CT Angiography in Patients With Diabetes and Suspected Coronary Artery Disease.
PubMed 文献 · J Am Coll Cardiol · 2019-01-01

PROMISE随机试验比较了糖尿病与非糖尿病患者中初始冠脉CTA策略与功能负荷试验策略的心血管结局。糖尿病患者中CTA组心血管死亡或心梗风险显著低于负荷试验组(1.1% vs 2.6%,校正HR 0.38,95%CI 0.18-0.79,P=0.01),非糖尿病患者无显著差异。提示CTA可作为糖尿病伴稳定胸痛患者的初始诊断策略。

要点

  • 糖尿病伴稳定胸痛患者,初始CTA策略较功能负荷试验减少心血管死亡或心梗。
  • 糖尿病患者CTA组事件率1.1%,负荷试验组2.6%,校正HR 0.38(95%CI 0.18-0.79)。
  • 非糖尿病患者两种策略的事件率无显著差异(校正HR 1.03,95%CI 0.69-1.54)。

核心结论

  • 在糖尿病伴稳定胸痛患者中,初始CTA策略较功能负荷试验策略带来更少的不良心血管结局。
  • CTA可考虑作为该亚组患者的初始诊断策略。

研究设计与样本

  • PROMISE为随机试验,评估稳定门诊疑似冠心病患者初始CTA策略与功能负荷试验策略。
  • 共纳入糖尿病患者1908例(21%)和非糖尿病患者7058例(79%),按随机分组比较心血管结局。

主要发现

  • 糖尿病患者中,CTA组心血管死亡或心梗发生率为1.1%(10/936),负荷试验组为2.6%(25/972)。
  • 糖尿病患者校正HR为0.38(95%CI 0.18-0.79,P=0.01)。
  • 非糖尿病患者中CTA组事件率1.4%(50/3564),负荷试验组1.3%(45/3494),校正HR 1.03(95%CI 0.69-1.54,P=0.887)。
  • 糖尿病交互项P值为0.02。

临床怎么用

  • 对糖尿病伴稳定胸痛、疑似冠心病患者,可优先考虑冠脉CTA作为初始无创诊断策略。
  • 非糖尿病患者中CTA与功能负荷试验的心血管结局无显著差异,选择需结合其他因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The optimal noninvasive test (NIT) for patients with diabetes and stable symptoms of coronary artery disease (CAD) is unknown. OBJECTIVES: The purpose of this study was to assess whether a diagnostic strategy based on coronary computed tomographic angiography (CTA) is superior to functional stress testing in reducing adverse cardiovascular (CV) outcomes (CV death or myocardial infarction [MI]) among symptomatic patients with diabetes. METHODS: PROMISE (Prospective Multicenter Imaging Study for Evaluation of Chest Pain) was a randomized trial evaluating an initial strategy of CTA versus functional testing in stable outpatients with symptoms suggestive of CAD. The study compared CV outcomes in patients with diabetes (n = 1,908 [21%]) and without diabetes (n = 7,058 [79%]) based on their randomization to CTA or functional testing. RESULTS: Patients with diabetes (vs. without) were similar in age (median 61 years vs. 60 years) and sex (female 54% vs. 52%) but had a greater burden of CV comorbidities. Patients with diabetes who underwent CTA had a lower risk of CV death/MI compared with functional stress testing (CTA: 1.1% [10 of 936] vs. stress testing: 2.6% [25 of 972]; adjusted hazard ratio: 0.38; 95% confidence interval: 0.18 to 0.79; p = 0.01). There was no significant difference in nondiabetic patients (CTA: 1.4% [50 of 3,564] vs. stress testing: 1.3% [45 of 3,494]; adjusted hazard ratio: 1.03; 95% confidence interval: 0.69 to 1.54; p = 0.887; interaction term for diabetes p value = 0.02). CONCLUSIONS: In diabetic patients presenting with stable chest pain, a CTA strategy resulted in fewer adverse CV outcomes than a functional testing strategy. CTA may be considered as the initial diagnostic strategy in this subgroup. (PROspective Multicenter Imaging Study for Evaluation of Chest Pain [PROMISE]; NCT01174550).

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Sharma A, Coles A, Sekaran NK, et al. Stress Testing Versus CT Angiography in Patients With Diabetes and Suspected Coronary Artery Disease. J Am Coll Cardiol. 2019. PMID: 30819356. doi:10.1016/j.jacc.2018.11.056

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。